Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation

Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation

Sodium glucose cotransporter 2 inhibitors (SGLT2i) are standard of care for type 2 diabetes mellitus, heart failure, and chronic kidney disease (CKD). Heart transplant (HTx) recipients are at increased risk of diabetes and CKD, and both are independently associated with increased mortality. In a ret...

Full description

Saved in:
Bibliographic Details
Main Authors: Lisa M. Raven, MBBS, FRACP, Jerry R. Greenfield, MBBS (Hons 1), PhD, FRACP, Andrew Jabbour, BSc (Med), MBBS (Hons), PhD, FRACP, Peter S. Macdonald, MBBS, MD, PhD, FRACP, Christopher A. Muir, MBBS (Hons), FRACP, PhD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JHLT Open
Subjects:
SGLT2
sodium glucose cotransporter 2
heart transplant
transplantation
kidney
renal
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425000503
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items